Agronomic portal Agronom.info
Categories
Language
Currency
My account
Rapeseed

ES LILO

Diseases
Sclerotinia, Phomosis
Country
France
Registration Year
2021
Manufacturer
Euralis Semences
No active offers.
Views
4
Reviews
0
Producer
Euralis Semences
Description ES LILO
ES LILO — winter rapeseed of medium early maturity, developed by the Lidea brand selection. The hybrid is characterized by high plant height and intensive branching, which contributes to high yield formation under various climatic conditions. Plants have medium-late flowering and resistance to autumn elongation of the root neck, ensuring stable development in the spring period. Rapeseed ES LILO is recommended for cultivation in the Polissia, Forest-Steppe, and Steppe zones, adapts well to low and medium quality soils, and positively responds to high agrofond supply. The hybrid has high oil content — about 47.8%, ensuring high oiliness and profitable sale of commercial grain. ES LILO exhibits high resistance to diseases such as phoma and sclerotinia, reducing the need for fungicides and lowering chemical load on the ecosystem. Additionally, the OGURA system hybrid shows high resistance to pod cracking, which helps preserve yield and improve its quality. An important feature is the content of 10.4% Omega-3 fatty acids, enhancing the nutritional value of the product. Rapeseed ES LILO has intensive early development, allowing sowing both in optimal and late periods. The recommended plant density at the time of spring vegetation renewal is 35–45 plants per square meter, and the optimal row spacing is 30–45 cm. Thanks to these characteristics, the hybrid ensures maximum yield at minimal costs and is suitable for universal use in various agroclimatic conditions.
Specifications ES LILO
Diseases
Sclerotinia
Sclerotiniosis
Phomosis
Phomosis
Type of Rape
Winter rape
Hybrid Type
Simple Linear
Oil Content
45-50%
Country
France
Registration Year
2021
Catalog
Varieties
Technical Crops
Manufacturer
Euralis Semences
Where to buy ES LILO
Loading...
Reviews ES LILO
0comments
Sort by:Popular first
No comments yet.